Quality-of-life results of an EORTC phase III randomized trial of adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases of solid tumors

被引：6
|
作者：
Soffietti, R.
Mueller, R. P.
Abacioglu, M. U.
Villa, S.
Fauchon, F.
Baumert, B.
Fariselli, L.
Tridello, G.
Kocher, M.
Bottomley, A.
机构：
[1] Univ Turin, Turin, Italy
[2] S Giovanni Battista Hosp, Turin, Italy
[3] Univ Cologne, D-50931 Cologne, Germany
[4] Marmara Univ, Istanbul, Turkey
[5] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[6] Ctr Haute Energie, Nice, France
[7] UMC, MAASTRO GROW Res Inst, Maastricht, Netherlands
[8] Fdn Ist Neurol, Milan, Italy
[9] European Org Res Treatment Canc, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.9036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9036
引用
收藏
页数：1
相关论文
共 47 条
  • [31] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
    Andrews, DW
    Scott, CB
    Sperduto, PW
    Flanders, AE
    Gaspar, LE
    Schell, MC
    Werner-Wasik, M
    Demas, W
    Ryu, J
    Bahary, JP
    Souhami, L
    Rotman, M
    Mehta, MP
    Curran, WJ
    LANCET, 2004, 363 (9422): : 1665 - 1672
  • [32] Hypofractionated Stereotactic Radiotherapy vs. Single Fraction Stereotactic Radiosurgery to the Resection Cavity of Brain Metastases after Surgical Resection (SATURNUS trial): A Prospective, Randomized Phase Ill Trial
    Waltenberger, M.
    Bernhardt, D.
    Diehl, C.
    Meyer, B.
    Straube, C.
    Wiestler, B.
    Wilkens, J.
    Zimmer, C.
    Combs, S. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E155 - E155
  • [33] Original Article A Randomised Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1-10 Brain Metastases
    Whitfield, G. A.
    Bulbeck, H.
    Clifton-Hadley, L.
    Edwards, D.
    Jefferies, S.
    Jenkinson, M. D.
    Griffin, M.
    Handley, J.
    Megias, D.
    Sanghera, P.
    Shaffer, R.
    Short, S.
    Wilson, W.
    CLINICAL ONCOLOGY, 2024, 36 (11) : 681 - 689
  • [34] RANDOMIZED PHASE III TRIAL COMPARING GAMMA KNIFE (GK) AND LINAC BASED (EDGE) RADIOSURGERY FOR BRAIN METASTASES FROM SOLID TUMORS: RESULTS FROM THE GADGET TRIAL
    Clerici, E.
    Navarria, P.
    Franzese, C.
    Carta, G. A.
    Mancosu, P.
    Reggiori, G.
    Picozzi, P.
    Attuati, L.
    Tomatis, S.
    Scorsetti, M.
    NEURO-ONCOLOGY, 2018, 20 : 227 - 227
  • [35] Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: An international randomized double-blind phase III trial
    Coens, C.
    Bottomley, A.
    Blank, C. U.
    Mandala, M.
    Long, G. V.
    Atkinson, V. G.
    Dalle, S.
    Haydon, A.
    Lichinitser, M.
    Khattak, A.
    Carlino, M. S.
    Sandhu, S. K.
    Larkin, J.
    Puig Sarda, S.
    Ascierto, P. A.
    Schadendorf, D.
    Ibrahim, N.
    Suciu, S.
    Robert, C.
    Eggermont, A. M. M.
    ANNALS OF ONCOLOGY, 2018, 29 : 456 - 456
  • [36] Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A
    Welzel, Grit
    Boch, Angela
    Sperk, Elena
    Hofmann, Frank
    Kraus-Tiefenbacher, Uta
    Gerhardt, Axel
    Suetterlin, Marc
    Wenz, Frederik
    RADIATION ONCOLOGY, 2013, 8
  • [37] Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A
    Grit Welzel
    Angela Boch
    Elena Sperk
    Frank Hofmann
    Uta Kraus-Tiefenbacher
    Axel Gerhardt
    Marc Suetterlin
    Frederik Wenz
    Radiation Oncology, 8
  • [38] A randomized phase III trial between adjuvant docetaxel and surveillance after radical radiotherapy (RT) for intermediate and high-risk prostate cancer (PC): Quality-of-life results (QoL) in SPCG-13 trial
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Hjalm-Eriksson, Marie
    Thellenberg-Karlsson, Camilla
    Astrom, Lennart
    Franzen, Lars
    Fransson, Ann-Sofie
    Leskinen, Markku J.
    Huttunen, Teppo
    Ginman, Claes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [39] Radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus radiotherapy alone for newly diagnosed glioblastoma (GBM): Overall results and recursive partitioning analysis (RPA) of a phase III randomized trial of the EORTC brain tumor and radiotherapy groups and the NCIC clinical trial group
    Mirimanoff, R
    Mason, W
    Kortmann, R
    Van den Bent, M
    Fisher, B
    Taphoorn, M
    Reni, M
    Curschmann, J
    Villa, S
    Cairncross, G
    Gorlia, T
    Stupp, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S162
  • [40] Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial
    Eggermont, Alexander M. M.
    Suciu, Stefan
    Rutkowski, Piotr
    Marsden, Jeremy
    Santinami, Mario
    Corrie, Philippa
    Aamdal, Steinar
    Ascierto, Paolo A.
    Patel, Poulam M.
    Kruit, Wim H.
    Bastholt, Lars
    Borgognoni, Lorenzo
    Bernengo, Maria Grazia
    Davidson, Neville
    Polders, Larissa
    Praet, Michel
    Spatz, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (30) : 3831 - +
12345